Because sufficient CD19+CD5+ cells infiltrated in tumour tissues can't be acquired for analysis of distinct CD1d expression levels, we only quantified the frequency of CD19+CD5+ cells in tumour tissues and peripheral blood (Figure S3). The gene discussed is CD5; the disease is neoplasm.